RedHill Biopharma wins Nasdaq extension to regain $1 minimum bid compliance by April 5, 2027

Nasdaq set a new compliance deadline of April 5, 2027 after an initial period ended Oct. 5, 2026; Nasdaq will close the matter if the ADS bid stays at or above $1.00 for 10 straight business days.